Skip to Main Content
Skip Nav Destination

Issues

Departments

Clinical Diabetes October 2003, Vol.21, 188-190. doi:https://doi.org/10.2337/diaclin.21.4.188
Clinical Diabetes October 2003, Vol.21, 190-192. doi:https://doi.org/10.2337/diaclin.21.4.190
Editorial
Clinical Diabetes October 2003, Vol.21, 148-149. doi:https://doi.org/10.2337/diaclin.21.4.148
Landmark Study
Clinical Diabetes October 2003, Vol.21, 151-152. doi:https://doi.org/10.2337/diaclin.21.4.151
Practical Pointer
Topics: statins
Clinical Diabetes October 2003, Vol.21, 168-172. doi:https://doi.org/10.2337/diaclin.21.4.168
Patient Information
Clinical Diabetes October 2003, Vol.21, 173. doi:https://doi.org/10.2337/diaclin.21.4.173
The Business of Diabetes
Clinical Diabetes October 2003, Vol.21, 175-178. doi:https://doi.org/10.2337/diaclin.21.4.175
Commentary
Clinical Diabetes October 2003, Vol.21, 181-182. doi:https://doi.org/10.2337/diaclin.21.4.181
Position Statement
Clinical Diabetes October 2003, Vol.21, 183-184. doi:https://doi.org/10.2337/diaclin.21.4.183
Council’s Voice
Clinical Diabetes October 2003, Vol.21, 186-187. doi:https://doi.org/10.2337/diaclin.21.4.186

Features

Clinical Diabetes October 2003, Vol.21, 154-161. doi:https://doi.org/10.2337/diaclin.21.4.154
Clinical Diabetes October 2003, Vol.21, 163-167. doi:https://doi.org/10.2337/diaclin.21.4.163
Close Modal

or Create an Account

Close Modal
Close Modal